INHALE-3: Afrezza® Combined With Insulin Degludec Versus Usual Care in Adults With Type 1 Diabetes
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Irl B. Hirsch, MD
University of Washington
Study Chair - Kevin Kaiserman, MD
Mannkind Corporation
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Loma Linda University-Diabetes Treatment Center
Loma Linda, California, United States
- Sansum Diabetes Research
Santa Barbara, California, United States
- Barbara Davis Center
Aurora, Colorado, United States
- Atlanta Diabetes Associates
Atlanta, Georgia, United States
- Northwestern University Division of Endocrinology, Metabolism and Molecular Medicine
Chicago, Illinois, United States
- Iowa Diabetes Research
West Des Moines, Iowa, United States
- Boston Medical Center
Boston, Massachusetts, United States
- Joslin Diabetes Center
Boston, Massachusetts, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Las Vegas Endocrinology
Henderson, Nevada, United States
- Endocrine Associate of West Village, Pc
Long Island City, New York, United States
- Mount Sinai Diabetes Center
New York, New York, United States
- Suny Upstate Medical University
Syracuse, New York, United States
- University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
- Texas Diabetes & Endocrinology, P.A.
Austin, Texas, United States
- the University of Texas Southwestern Medical Center
Dallas, Texas, United States
- Diabetes and Glandular Disease Clinic, P.A.
San Antonio, Texas, United States
- University of Washington Diabetes Institute
Seattle, Washington, United States
- Mountain State Diabetes
Parkersburg, West Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 7 Jul 2023
- Primary completion
- 26 Mar 2024
- Completion
- 24 Jun 2024
- Last update posted
- 9 Aug 2024
- Registered enrollment
- 141
- Registry id
- NCT05904743
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.